Hims & Hers launches GLP-1 tracker amid shortages

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

The tracker allows patients to report shortages of GLP-1 drugs by submitting their location and which brand of drug they are unable to access. The company plans to aggregate this data and publish updates to demonstrate to the FDA that supply shortages persist.